Find the right retinol alternatives for your sensitive skincare needs. Compare gentle ingredients like bakuchiol, peptides, ...

A new review was published in Volume 13 of Oncoscience on May 22, 2026, titled "Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression." ...

Fossil fuels will dominate India's energy for 10-15 years, says BPCL's Anurag Saraogi. He states that biofuels will ...

Detailed price information for Arcutis Biotherapeutics Inc (ARQT-Q) from The Globe and Mail including charting and trades.

EMERGE is a global, randomized, multicenter, placebo-controlled Phase 3 trial that will evaluate claseprubart 300mg/2mL S.C. dosed Q2W and Q4W vs. placebo, with top-line results anticipated in 2H'28 ...

Advancing a neuromuscular franchise with claseprubart, a highly potent investigational classical pathway inhibitor, across generalized Myasthenia Gravis (gMG), Multifocal Motor Neuropathy (MMN) and ...

Omeros Corporation (Nasdaq: OMER) announced today an update on the review by the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) of the company’s marketing ...

Individuals entering the legal profession using alternative pathways to take the bar exam have been less likely to pass the bar, less likely to find employment at law firms and more likely to later be ...

The Centers for Medicare & Medicaid Services (CMS) and the Food and Drug Administration (FDA) recently issued two related proposals that, taken together, would significantly alter the pathways ...

Managing complement 3 glomerulopathy involves several treatment options aimed at slowing disease progression and protecting kidney function. These may include blood pressure control, steroids, ...

The law, effective Oct. 1, 2026, will create a third pathway that allows candidates to earn their CPA license with a bachelor's degree, two years of experience and passage of the CPA exam. The two ...